Agency Links:   Home  Contact Us   Help   Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

Lymphoma & Myeloma

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use, available at www.bccancer.bc.ca/legal.htm.

Please note: See Leukemia/ BMT for Bone Marrow Transplant protocols. All links in the table below open PDF documents.

PROTOCOL CODE and DESCRIPTION AVAILABLE DOCUMENTS
(revision date indicated in red)
LYABVD: Treatment of Hodgkin's disease with Doxorubicin, Bleomycin, Vinblastine and Dacarbazine. Protocol (01 May 2009)
- Preprinted order (01 May 2009)
- Patient Handout (01 Oct 2003)
ULYALEM: Treatment of Fludarabine-Refractory B-Chronic Lymphocytic Leukemia (B-CLL) and T-Prolymphocytic Leukemia (T-PLL) with Alemtuzumab. - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
LYCCOP: Treatment of Hodgkin's disease using Cyclophosphamide, Vincristine, Prednisone. - Protocol (01 May 2009)
LYCDA: Treatment of Hairy Cell Leukemia with Cladribine. - Protocol (01 May 2009)
- Preprinted order (01 July 2009)
LYCHLOR: Therapy for Low Grade Lymphoma and Chronic Lymphocytic Leukemia Using C hlorambucil. - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
LYCHOP: Treatment of Lymphoma with Doxorubicin, Cyclophosphamide, Vincristine and Prednisone. - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
LYCHOP-R: Treatment of Lymphoma with Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab. - Protocol (01 Jun 2009)
- Preprinted order (01 Oct 2009)
- Patient Handout (01 Oct 2006)
LYCODOXMR: Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Cyclophosphamide, Vincristine, Doxorubicin, Methotrexate, Leucovorin (CODOX-M) and Rituximab. - Protocol (01 Jun 2009)
- Preprinted order (01 Oct 2009)
LYCSPA: Cyclosporine for cytopenias associated with lymphoproliferative disorder of large granular lymphocytes. - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
LYCVP: Advanced indolent lymphoma using Cyclophosphamide, Vincristine and Prednisone. - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
LYCVPPABO: Treatment of Hodgkin's Disease with Cyclophosphamide, Vinblastine, Procarbazine And Prednisone. - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
LYCVP-R: Treatment of Advanced Indolent Lymphoma using Cyclophosphamide, Vincristine, Prednisone and Rituximab (CVP-R). - Protocol (01 Jun 2009)
- Preprinted order (01 Oct 2009)
- Patient Handout (01 Feb 2006)
LYCYCLO: Therapy of Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia or Multiple Myeloma Using Cyclophosphamide. - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
LYFLU: Treatment of Low-Grade Lymphoma or Chronic Lymphocytic Leukemia with Fludarabine. - Protocol (01 May 2009)
- Preprinted order (01 June 2009)
LYFLUDR: Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and Rituximab. - Protocol (01 Jun 2009)
- Preprinted order (01 Oct 2009)
LYGDP: Treatment of Lymphoma with Gemcitabine, Dexamethasone and Cisplatin (GDP). - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
LYHDMRP: Treatment of Primary Intracerebral Lymphoma with High Dose Methotrexate and Rituximab - Protocol (01 May 2009)
LYHDMTXP: Treatment of Primary Intracerebral Lymphoma with High Dose Methotrexate. - Protocol (01 May 2009)
LYHDMTXR: Treatment of Leptomeningeal Lymphoma or Recurrent Intracerebral Lymphoma with High Dose Methotrexate. - Protocol (01 May 2009)
LYIT: Treatment of Lymphoma using Intrathecal Methotrexate and Cytarabine - Protocol (01 May 2009)
- Preprinted order (01 Sep 2009)
LYIVACR: Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Ifosfamide, Mesna, Etoposide, Cytarabine (IVAC) and Rituximab - Protocol (01 Feb 2010)
- Preprinted order (01Oct 2009)
ULYMFBEX: Treatment for refractory cutaneous T-cell lymphoma using Bexarotene (Note: approval from the Health Canada Special Access Programme required). - Protocol (01 May 2009)
- Preprinted order (01 Dec 2009)
ULYMFECP: Treatment of Cutaneous T-cell Lymphoma (Sézary syndrome) with Extracorporeal Photopheresis. - Protocol (01 May 2009)
LYPALL: Lymphoma Palliative Chemotherapy. - Protocol (01 May 2009)
ULYRICE: Treatment of Advanced Stage Large B-Cell Non-Hodgkin’s Lymphoma with Ifosfamide, Carboplatin, Etoposide and Rituximab - Protocol (01 Jun 2009)
- Preprinted order (01 June 2009)
LYRITB: Summary for Palliative Therapy For Lymphoma Using Radioimmunotherapy: Tositumomab-Priming for I131 Tositumomab - Protocol (01 Jun 2009)
- Preprinted order (01 June 2009)
LYRITUX: Treatment of Lymphoma with single agent Rituximab. - Protocol (01 Jun 2009)
- Preprinted order (01 Oct 2009)
LYRITZ: Palliative Therapy For Lymphoma Using Radioimmunotherapy: Rituximab-Priming for Ibritumomab 90Y - Protocol (01 Jun 2009)
- Preprinted order (01 Oct 2009)
ULYRMTN: Maintenance Rituximab for Indolent Lymphoma. - Protocol (01 Jun 2009)
Preprinted order (01 Feb 2010)
UMYBORTEZ: Treatment of Multiple Myeloma with Bortezomib and Dexamethasone - Protocol (01 Feb 2010)
- Preprinted order (01 Dec 2009)
UMYCTD: Treatment of Systemic Light-chain (AL) Amyloidosis and Multiple Myeloma Using Cyclophosphamide, Thalidomide and Dexamethasone. Protocol (01 May 2009)

UMYLENDEX: Therapy of Multiple Myeloma Using Lenalidomide with Dexamethasone Protocol (01 Feb 2010)
- Preprinted order (01 Oct 2009)
Patient Handout (01 Feb 2010)
MYMP: Treatment of Multiple Myeloma Using Melphalan and Prednisone. - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
UMYMPBOR: Treatment of Multiple Myeloma using Melphalan, Prednisone and Weekly Bortezomib Protocol (01 Feb 2010)
Preprinted order (01 Dec 2009)
UMYMPT: Treatment of Multiple Myeloma Using Melphalan, Prednisone and Thalidomide. Protocol (01 Oct 2009)
MYPAM: Treatment of Multiple Myeloma with Pamidronate - Protocol (01 May 2009)
- Preprinted order (01 May 2009)
UMYTHALID: Therapy of Multiple Myeloma Using Thalidomide - Protocol (01 May 2009)
- Preprinted order (01 May 2009)

The BC Cancer Agency is a part of the Provincial Health Services Authority .
If you notice a problem with this page, please report it via the Bug Report Form.
Copyright © 2010. BC Cancer Agency. All Rights Reserved. | Terms of Use | Privacy

Unofficial document if printed. Please refer to the following web address for up-to-date information: http://www.bccancer.bc.ca/HPI/ChemotherapyProtocols/Lymphoma/default.htm